24/02/2010

Gardasil highly effective at preventing pre-cancerous anal lesions in gay men

The genital wart vaccine Gardasil is highly effective at preventing pre-cancerous anal lesions in younger gay men, according to the results of a study presented to a recent conference.

Delegates to the European Research Organization on Genital Infection and Neoplasia were told that Gardasil reduced the risk of pre-cancerous anal lesions by 78% in a Phase III, randomised, placebo-controlled trial involving gay and other men who have sex with men aged between 18 and 26.

Gay men, especially those with HIV, have higher rates of anal cancer than those seen in the general population, therefore the high efficacy of the vaccine is encouraging.

Research involving younger women has shown that Gardasil is highly effective at preventing pre-cancerous and cancerous cell cervical cell changes caused by human papilloma virus (HPV). Gardasil provides protection against four high risk types of the virus: HPV 6, 11, 16 and 18.

Investigators wished to determine the efficacy and safety of the vaccine in younger gay men.

The randomised, placebo controlled trial involved 598 men. None were infected with HPV strains 6, 11, 16 and 18 on entry to the study. Half were provided with two doses of the vaccine, the others with a placebo. They were then followed for an average of two and a half years and rates of pre-cancerous anal cell changes and anal cancer were compared between the two groups.

High-risk HPV-associated pre-cancerous cell changes were detected in five men who received Gardasil compared to 24 of the individuals who were given the placebo. The investigators therefore calculated that Gardasil reduced the risk of such cell changes by 78%.

No patient in either study arm developed anal cancer.

Gardasil appeared safe, with similar numbers of patients in the vaccine and placebo study arms reporting severe side-effects.

By Michael Carter

Reference
Palefsky J et al. Efficacy of Gardasil in men aged 16-26 naïve to vaccine HPV types at baseline: the latest data. 9th European Research Organization on Genital Infection and Neoplasia Congress, abstract TC 4-2, Monte Carlo, 2010.

Aidsmap

http://www.aidsmap.com/

http://www.aidsmap.com/en/news/597D1B5C-9FE7-4932-9A6B-13C05029C1B1.asp

Share this page

More...

DISCLAIMER

The EATG is not responsible for the content of this article. It does not necessarily reflect EATG views or opinions.

FAIR USE NOTICE

The information above may contain copyrighted material which has not always been specifically authorised by the copyright owner. Such material is made available for educational purposes to advance the understanding of scientific, ethical, legal and social issues. It is believed that this constitutes a 'fair use' of any such copyrighted material. This material is distributed without profit via the subscription to the daily digest.